Ischemic Tolerance - Blessing or Curse

Overview

Journal Physiol Res

Specialty Physiology

Date 2021 Sep 10

PMID 34505532

Citations 1

Authors

J Burda

R Burda

Affiliations

Soon will be listed here.

Abstract

Application of knowledge about ischemic tolerance to clinic requires the solid understanding of mechanism of creation of this phenomenon. This review summarizes research that has been carried out in many laboratories over a long period of time, but the main focus will be on own experimental research. The main emphasis is devoted to the possibility of preparing full tolerance in the donor's body and its transfer to the patient in the form of activated blood plasma. Such plasma could be administered as soon as the patient is transported to the hospital and would take effect immediately after administration to the patient's bloodstream. One chapter is also devoted to anticonditioning, i.e. the possibility of preventing the activation of tolerance. Anticonditioning could be used to treat oncologic patients. We expect that this method could increase effectiveness of cancer treatment. Cross-tolerance with a wide range of diverse stressors gives us the courage to assume that activated plasma can significantly help with a wide range of pathological events.

Citing Articles

Experimental Modeling of Damaging and Protective Hypoxia of the Mammalian Brain.

Semenov D, Belyakov A, Rybnikova E J Evol Biochem Physiol. 2022; 58(6):2021-2034.

PMID: 36573160 PMC: 9773672. DOI: 10.1134/S0022093022060291.

References

Atar S, Ye Y, Lin Y, Freeberg S, Nishi S, Rosanio S . Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. Am J Physiol Heart Circ Physiol. 2005; 290(5):H1960-8. DOI: 10.1152/ajpheart.01137.2005. View

Chen Y, Ginis I, Hallenbeck J . The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells. J Cereb Blood Flow Metab. 2001; 21(1):34-40. DOI: 10.1097/00004647-200101000-00005. View

Kirino T . Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982; 239(1):57-69. DOI: 10.1016/0006-8993(82)90833-2. View

Kuroiwa T, Yamada I, Endo S, Hakamata Y, Ito U . 3-Nitropropionic acid preconditioning ameliorates delayed neurological deterioration and infarction after transient focal cerebral ischemia in gerbils. Neurosci Lett. 2000; 283(2):145-8. DOI: 10.1016/s0304-3940(00)00937-x. View

Kokosova N, Danielisova V, Smajda B, Burda J . Ionizing radiation as preconditioning against transient cerebral ischemia in rats. Gen Physiol Biophys. 2014; 33(4):403-10. DOI: 10.4149/gpb_2014021. View

Burda J, Martin M, Garcia A, Alcazar A, Fando J, Salinas M . Phosphorylation of the alpha subunit of initiation factor 2 correlates with the inhibition of translation following transient cerebral ischaemia in the rat. Biochem J. 1994; 302 ( Pt 2):335-8. PMC: 1137233. DOI: 10.1042/bj3020335. View

Durukan A, Tatlisumak T . Preconditioning-induced ischemic tolerance: a window into endogenous gearing for cerebroprotection. Exp Transl Stroke Med. 2010; 2(1):2. PMC: 2830184. DOI: 10.1186/2040-7378-2-2. View

Zhang W, Miao Y, Zhou S, Jiang J, Luo Q, Qiu Y . Neuroprotective effects of ischemic postconditioning on global brain ischemia in rats through upregulation of hippocampal glutamine synthetase. J Clin Neurosci. 2011; 18(5):685-9. DOI: 10.1016/j.jocn.2010.08.027. View

Murry C, Jennings R, Reimer K . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74(5):1124-36. DOI: 10.1161/01.cir.74.5.1124. View

10.

Dienel G, Pulsinelli W, Duffy T . Regional protein synthesis in rat brain following acute hemispheric ischemia. J Neurochem. 1980; 35(5):1216-26. DOI: 10.1111/j.1471-4159.1980.tb07878.x. View

11.

Dillon J, Laing A, Chandler J, Wang J, McGuinness A, Redmond H . Pravastatin attenuates tourniquet-induced skeletal muscle ischemia reperfusion injury. Acta Orthop. 2006; 77(1):27-32. DOI: 10.1080/17453670610045669. View

12.

Dirnagl U, Meisel A . Endogenous neuroprotection: mitochondria as gateways to cerebral preconditioning?. Neuropharmacology. 2008; 55(3):334-44. DOI: 10.1016/j.neuropharm.2008.02.017. View

13.

Pagliaro P, Femmino S, Popara J, Penna C . Mitochondria in Cardiac Postconditioning. Front Physiol. 2018; 9:287. PMC: 5879113. DOI: 10.3389/fphys.2018.00287. View

14.

Hao Y, Xin M, Feng L, Wang X, Wang X, Ma D . Review Cerebral Ischemic Tolerance and Preconditioning: Methods, Mechanisms, Clinical Applications, and Challenges. Front Neurol. 2020; 11:812. PMC: 7530891. DOI: 10.3389/fneur.2020.00812. View

15.

Kristian T, Siesjo B . Calcium-related damage in ischemia. Life Sci. 1996; 59(5-6):357-67. DOI: 10.1016/0024-3205(96)00314-1. View

16.

Shimizu M, Tropak M, Diaz R, Suto F, Surendra H, Kuzmin E . Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection. Clin Sci (Lond). 2009; 117(5):191-200. DOI: 10.1042/CS20080523. View

17.

Wada K, Miyazawa T, Nomura N, Yano A, Tsuzuki N, Nawashiro H . Mn-SOD and Bcl-2 expression after repeated hyperbaric oxygenation. Acta Neurochir Suppl. 2001; 76:285-90. DOI: 10.1007/978-3-7091-6346-7_59. View

18.

Pignataro G, Brancaccio P, Laudati G, Valsecchi V, Anzilotti S, Casamassa A . Sodium/calcium exchanger as main effector of endogenous neuroprotection elicited by ischemic tolerance. Cell Calcium. 2020; 87:102183. DOI: 10.1016/j.ceca.2020.102183. View

19.

Loukogeorgakis S, Williams R, Panagiotidou A, Kolvekar S, Donald A, Cole T . Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism. Circulation. 2007; 116(12):1386-95. DOI: 10.1161/CIRCULATIONAHA.106.653782. View

20.

Lehotsky J, Burda J, Danielisova V, Gottlieb M, Kaplan P, Saniova B . Ischemic tolerance: the mechanisms of neuroprotective strategy. Anat Rec (Hoboken). 2009; 292(12):2002-12. DOI: 10.1002/ar.20970. View